Taken together, our data show that downregulation of PTHLH reduces MYCN expression, tumor growth, invasion, and migration in a MYCN‐amplified and TP53‐mutated neuroblastoma cell lines exhibiting high levels of PTH1R. The gene discussed is TP53; the disease is neuroblastoma.